Mesoscale evaluation of SARS-COV-2 antibodies’ ability to block ACE2-binding from various parts of the spike protein.

Flow-cytometric evaluation of SARS-COV-2 binding antibodies against a cell-line over-expressing the spike-protein.

Intracellular signaling cascade (ERK-pathway) is inhibited by the MEK-inhibitor Trametinib in cancer cells.